Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Condition(s):Pancreatic AdenocarcinomaLast Updated:November 18, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic AdenocarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Kidney CancerLast Updated:September 27, 2016Unknown status
Condition(s):Prostate CancerLast Updated:December 16, 2020Active, not recruiting
Condition(s):Pancreatic CancerLast Updated:August 3, 2022Completed
Condition(s):Prostate CancerLast Updated:February 20, 2015Completed
Condition(s):Tonsillar HypertrophyLast Updated:January 23, 2024Recruiting
Condition(s):Refractory Paroxysmal Atrial FibrillationLast Updated:March 28, 2024Active, not recruiting
Condition(s):Kidney CancerLast Updated:November 24, 2014Unknown status
Condition(s):Unresectable Pancreatic CancerLast Updated:February 16, 2024Active, not recruiting
Condition(s):Recurrent Liver CarcinomaLast Updated:September 12, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.